By employing a strategy parallel to that described above for treatment, PET/CT and SPECT/CT (a technique that allows for the precise description of tissue perfusion and functionality) can be augmented for targeted detection of HER2-positive breast cancer. The gene discussed is ERBB2; the disease is breast cancer.